Patients with cancer at the margins of reproductive age had reduced levels of anti‐Müllerian hormone compared with patients experiencing infertility (original) (raw)

Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies

Frank Jong

Human Reproduction, 2008

View PDFchevron_right

Anti-Mullerian Hormone and Antral Follicle Count Reveal a Late Impairment of Ovarian Reserve in Patients Undergoing Low-Gonadotoxic Regimens for Hematological Malignancies

Alessio Perandini

The Oncologist, 2013

View PDFchevron_right

Anti-Müllerian Hormone and Antral Follicle Count Reveal a Late Impair- Ment of Ovarian Reserve in Patients Undergone Low Gonadotoxic Regimens for Haematological Malignancies

Alessio Perandini

2013

View PDFchevron_right

The effect of cancer treatment on female fertility and strategies for preserving fertility

Theodoros Maltaris, Heinz Koelbl

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007

View PDFchevron_right

Endocrine function and fertility preservation in women surviving cancer : a study on cancer treatment and fertility

Matthys Botha

View PDFchevron_right

Anti-Müllerian Hormone as a Sensitive Marker of Ovarian Function in Young Cancer Survivors

Beata Zelazowska-rutkowska

International Journal of Endocrinology, 2013

View PDFchevron_right

Reproduction post-chemotherapy in young cancer patients

D. Meirow

Molecular and Cellular Endocrinology, 2000

View PDFchevron_right

Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation

ariel revel

BMC Women's Health, 2021

View PDFchevron_right

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results

Cécile Gallo, C. Lefebvre, C. Decanter

Reproductive BioMedicine Online, 2010

View PDFchevron_right

OPTIONS TO PRESERVE FERTILITY BEFORE ONCOLOGICAL TREATMENT: CRYOPRESERVATION OF OVARIAN TISSUE AND ITS CLINICAL APPLICATION

P. Simon, Yvon Englert

Acta Clinica Belgica, 2006

View PDFchevron_right

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

Yasmin Gosiengfiao, Maureen Prewitt

Fertility and Sterility, 2013

View PDFchevron_right

Fertility Preservation in Female Cancer Patients: A Review

Pablo Sanhueza

Journal of Safog With Dvd, 2009

View PDFchevron_right

How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries

Zeev Blumenfeld

The Oncologist, 2007

View PDFchevron_right

Impact of cancer therapies on ovarian reserve

Maureen Prewitt

Fertility and Sterility, 2012

View PDFchevron_right

Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation

Joseph Lessing

Fertility and Sterility, 2012

View PDFchevron_right

Fertility preservation strategies in women undergoing chemotherapy for haematological malignancy

Igor Crha, Martin Huser, Pavel Ventruba

European Clinics in Obstetrics and Gynaecology, 2006

View PDFchevron_right

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

Mikkel Rosendahl, Tom Kelsey

View PDFchevron_right

Fertility preservation in women with malignant tumors and gonadotoxic treatments

Michael Von Wolff

Deutsches Ärzteblatt international, 2012

View PDFchevron_right

Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer

SAMEERA AHMED

Journal of Cancer Survivorship, 2014

View PDFchevron_right

Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women

Marcus Sjödin

Human Reproduction, 2019

View PDFchevron_right

Longitudinal observation of serum anti-Müllerian hormone in three girls after cancer treatment

Makiko Tachibana

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2016

View PDFchevron_right

A Warning Call for Fertility Preservation Methods for Women Undergoing Gonadotoxic Cancer Treatment

Andreea Carp-Veliscu

Medicina, 2021

View PDFchevron_right

Fertility preservation in women with cancer: update and perspectives

Fernanda Parreiras

Revista Médica de Minas Gerais, 2013

View PDFchevron_right

Fertility Preservation in Female Cancer Patients

Simona Vailati, Eleonora Matteucci, Massimo Moscarini, F. Peccatori

Fertility and Sterility, 2005

View PDFchevron_right

Timing of fertility preservation procedures in a cohort of female patients with cancer

Leoni Louwé

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2012

View PDFchevron_right

The Late Effects of Cancer Treatment on Female Fertility and the Current Status of Fertility Preservation—A Narrative Review

Hanna Nilsson

Life

View PDFchevron_right

Infertility in reproductive‐age female cancer survivors

Gwendolyn Quinn

View PDFchevron_right

Acute onset of ovarian dysfunction in young females after start of cancer treatment

Ingrid Øra

Pediatric Blood & Cancer, 2013

View PDFchevron_right

Fertility-sparing in cancer patients

Milan Terzic

Clinical and Experimental Obstetrics & Gynecology

View PDFchevron_right

Methods for preserving fertility in young women suffering from cancer: some aspects of ovarian tissue cryopreservation

M. Sedlackova

Bratislava Medical Journal, 2012

View PDFchevron_right

Combination of fertility preservation strategies in young women with recently diagnosed cancer

Petr Janku, Igor Crha, Martin Huser

European journal of gynaecological oncology

View PDFchevron_right

Assessing The Impact Of Cancer Therapies On Ovarian Reserve

jill ginsberg

Fertility and Sterility

View PDFchevron_right